Rabetan Tablet 20/800 Milligrams

Adult dosage

Gastric ulcer and duodenal ulcer: Administer 20/800mg orally once daily according to symptoms. Typically, it is administered for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 20/800mg once daily for 4 to 8 weeks. If symptoms do not resolve after an 8-week course of proton pump inhibitors (PPIs), an additional 20/800mg can be administered orally twice daily for another 8 weeks.

This medication should not be used by patients who are allergic to certain components, are taking atazanavir or rilpivirine, or are pregnant or breastfeeding. Patients with poor liver function or kidney problems, elderly patients, patients with heart or lung issues, and those with severe gastrointestinal ulcers should exercise caution while using this medication. This medication contains sodium bicarbonate and Yellow No. 4 (tartrazine), so patients with electrolyte imbalances or allergies to specific dyes should be particularly cautious. During administration, symptoms such as skin rash, itching, blood abnormalities, liver function abnormalities, and heart or gastrointestinal disturbances may occur, so any symptoms should be immediately discussed with healthcare professionals. Long-term use requires regular blood tests and liver function tests, and caution is needed, especially for those taking it for over a year, as there may be an increased risk of fractures and hypomagnesemia. This medication suppresses stomach acid secretion, which may slightly increase the risk of bacterial infections in the gastrointestinal tract, and persistent diarrhea symptoms should be reported to healthcare professionals. Patients should exercise caution while driving or operating machinery due to the possibility of drowsiness or dizziness. There may be interactions with other medications, so it is essential to inform healthcare professionals of any medications being taken, particularly when combined with warfarin, methotrexate, atazanavir, and rilpivirine. Pregnant or breastfeeding women should not use this medication, and elderly patients may experience side effects more readily due to reduced liver function, so caution is warranted. Safety in children has not been established, so it is advisable not to use this medication in pediatric patients. In case of overdose, there is no specific antidote, so treatment should be symptomatic, and this medication should be swallowed whole and not chewed or crushed. It should be stored in a tightly sealed container away from moisture and not transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headaches, thunderclap headaches, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Rash
• itching
• decreased red blood cells
• decreased white blood cells
• increased white blood cells
• increased eosinophils
• increased neutrophils
• decreased lymphocytes
• anemia
• petechial hemorrhage

This medication should be stored in a tightly sealed container to avoid moisture and is preferably kept at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the medication's efficacy and safety.

Appearance

White round tablet

Package unit

28 tablets/bottle